Lexicon Pharmaceuticals LXRX Net Income
Net Income at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Lexicon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The official record: Lexicon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lexicon Pharmaceuticals's net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lexicon Pharmaceuticals's net income?
- Lexicon Pharmaceuticals (LXRX) reported net income of -$1.04M in Q1 2026.
- How has Lexicon Pharmaceuticals's net income changed year-over-year?
- Lexicon Pharmaceuticals's net income increased by 95.9% year-over-year, from -$25.3M to -$1.04M.
- What is the long-term trend for Lexicon Pharmaceuticals's net income?
- Over 4 years (2021 to 2025), Lexicon Pharmaceuticals's net income has grown at a -13.0% compound annual growth rate (CAGR), from -$87.76M to -$50.34M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.